Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-β1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system

Journal of Cellular Physiology

Volumn 180, Issue 1, 1999, Pages 61-70

  Ghahary, Aziz ^a   Tredget, Edward E ^a   Shen, Qiong ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; CELL GROWTH; FIBROBLAST; GROWTH REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; PATHOGENESIS; PRIORITY JOURNAL; WOUND HEALING;

AUTOCRINE COMMUNICATION; BLOTTING, NORTHERN; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INSULIN-LIKE GROWTH FACTOR II; KERATINOCYTES; MOLONEY MURINE LEUKEMIA VIRUS; PARACRINE COMMUNICATION; RECEPTOR, IGF TYPE 2; RNA, MESSENGER; SKIN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

MUSTELA VISON;

EID: 0033008016     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199907)180:1<61::AID-JCP7>3.0.CO;2-R     Document Type: Article

References (38)

1. Allen JB, Wong HL, Costa P, Simon GL, Bienkowski MJ, Wahl SM. 1993. Suppression of monocyte function and differential regulation of IL-1 and IL-4 contribute to resolution of experimental arthritis. J Immunol 151:4344-4351.
2. Border WA, Noble NA. 1994. Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292.
3. Border WA, Noble NA. 1995a. Targeting TGF-β for treatment of disease. Nature Med 1:1000-1001.
4. Border WA, Noble NA. 1995b. Fibrosis linked to TGF-β in yet another disease. J Clin Invest 96:655-656.
5. Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294-5299.
6. Dallas SL, Park-Snyder S, Miyazono K, Twardzik D, Mundy GR, Bonewald LF. 1994. Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. J Biol Chem 269:6815-6821.
7. Danielpour, D. 1993. Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1. J Immunol Meth 158:17-25.
8. Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB. 1989. Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells. J Cell Physiol 138:79-86.
9. de Bleser PJ, Jannes P, Van Buul-Offers SC, Hoogerbrugge CM, Van Schravendijk CFH, Niki T, Rogiers V, Van Den Brande JL, Wisse E, Geerts A. 1995. Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on CC14-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells. Hepatology 21:1429-1437.
10. Dennis PA, Rifkin DB. 1991. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88:580-584.
11. Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Docherty AJP, Angel P, Heath JK. 1987. Transforming growth factor-beta stimulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904.
12. Ghahary A, Murphy L. 1989. Uterine insulin-like growth factor-1 receptors: regulation of estrogen and variation throughout the estrous cycle. Endocrinology 125:597-604.
13. Ghahary A, Shen YJ, Scott PG, Tredget EE. 1994. Expression of mRNA for transforming growth factor-β1 is reduced in hypertrophic scar and normal dermal fibroblasts following serial passagein vitro. J Invest Dermatol 103:684-686.
14. Ghahary A, Pannu R, Tredget EE. 1996. Fibrogenic and anti-fibrogenic factors in wound repair. In: Molhotra SK, editor. Advances in structural biology. London: JAI Press. p 197-232.
15. Ghahary A, Tredget EE, Chang LJ, Scott PG, Shen Q. 1998a. Genetically modified dermal keratinocytes express high levels of transforming growth factor-β1. J Invest Dermatol 110:800-805.
16. Ghahary A, Shen Q, Shen YJ, Scott PG, Tredget EE. 1998b. Induction of transforming growth factor β1 by insulin-like growth factor-1 in dermal fibroblasts. J Cell Physiol 174:301-309.
17. Ignotz RA, Massague J. 1986. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337-4345.
18. Jullien P, Breg TM, Lawrence DA. 1989. Acid cellular environments: activation of latent TGF-beta and sensitization of cellular responses to TGF-beta and EGF. Int J Cancer 43:886-891.
19. Kanzaki T, Olofsson A, Moren A, Wernstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin C. 1991. TGF-beta 1 binding protein: a component of the large latent complex of TGF-beta 1 with multiple repeat sequences. Cell 61:1051-1061.
20. Kirschenlohr HL, Metcalfe JC, Weissberg PL, Grainger DJ. 1993. Adult human smooth muscle cells in culture produce active TGF-beta. Am J Physiol 63:C571-576.
21. Kovacina KS, Steele-Perkins G, Purchio AF, Lioubin M, Miyazono K, Heldin CH, Roth RA. 1989.Interactions of recombinant and platelet transforming growth factor-beta 1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem Biophys Res Commun 160:393-403.
22. Lyons RM, Keski-Oja J, Moses HL. 1988. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 106:1659-1665.
23. MacDonald RG, Pfeffer SR, Coussens L, Tepper MA, Brocklebank CM, Mole JE, Anderson JK, Chen E, Czech MP, Ullrich A. 1988. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science 239:1134-1137.
24. Moren A, Olofsson A, Stenman G, Sahkin P, Kanzaki T, Claesson-Welsh L, ten Dijike P, Miyazono K, Heldin CH. 1994. Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. J Biol Chem 269:32469-32478.
25. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. 1997. Latent transforming growth factor-β: structural features and mechanism of activation. Kidney Int 51:1376-1382.
26. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF. 1987. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 237:1333-1336.
27. Overall C, Wrana JL, Sodeck J. 1989. Independent regulation of collagense, 72 kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 264:1860-1869.
28. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. 1987. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 165:251-256.
29. Purchio AF, Cooper JA, Brunner AM, Lioubin M, Gentry LE, Kovacina KS, Roth RA, Marquardt H. 1988. Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-beta 1 precursor. J Biol Chem 263: 14211-14215.
30. Rheinwald JG, Green H. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6(3):331-343.
31. Roberts AB, Sporn MB. 1990. The transforming growth factor-β. In: Sporn MB, Roberts AB, editors. Peptide growth factors and their receptors. New York: Springer-Verlag. p 421.
32. Roberts AB, Assoian RK, Sporn MB, Smith JM, Roche S, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS. 1986. Transforming growth factor beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171.
33. Schults-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich GE. 1994. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem 269:26775-26782.
34. Sporn MB, Roberts AB, Wakefield LM, Associan RK. 1986. Transforming growth factor-β: biological function and chemical structure. Science 233:532-534.
35. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. 1987. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105:1039-1045.
36. Tsuji T, Okada F, Yamaguchi K, Nakamura T. 1990. Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNAin various rat tissues. Proc Natl Acad Sci USA 87:8835-8839.
37. Wakefield LM, Smith DM , Masui T, Harris CC, Sporn MB. 1987. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 105:965-975.
38. Wakefield LM, Smith DM, Flanders KC, Sporn MB. 1988. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem 263:7646-7654.